crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 526630

Časopis

Autori: Petrović, Igor; Dobrić, Ivan; Drviš, Petar; Shejbal, Dražen; Brčić, Luka; Boban Blagaić, Alenka; Batelja, Lovorka; Kokić, Neven; Tonkić, Ante; Miše, Stjepan; Baotić, Tomislav; Starešinić, Mario; Radić, Božo; Jakir, Ana; Vukšić, Tihomir; Anić, Tomislav; Seiwerth, Swen; Sikirić, Predrag
Naslov: An Experimental Model of Prolonged Esophagitis With Sphincter Failure in the Rat and the Therapeutic Potential of Gastric Pentadecapeptide BPC 157
( An Experimental Model of Prolonged Esophagitis With Sphincter Failure in the Rat and the Therapeutic Potential of Gastric Pentadecapeptide BPC 157 )
Izvornik: Journal of pharmacological sciences (1347-8613) 102 (2006), 3; 269-277
Vrsta rada: članak
Ključne riječi: BPC 157; esophagitis; sphincter (rat)
( BPC 157; esophagitis; sphincter (rat) )
Sažetak:
We report a simple novel rat model that combines prolonged esophagitis and parallel sphincters failure. The anti-ulcer gastric pentadecapeptide BPC 157, which was found to be stable in gastric juice, and is being evaluated in inflammatory bowel disease trials, is an antiesophagitis therapy that recovers failed sphincters. Twelve or twenty months after the initial challenge (tubes sutured into sphincters for one week and then spontaneously removed by peristalsis), rats exhibit prolonged esophagitis (confluent hemorrhagic and yellowish lesions, thinner epithelium and superficial corneal layer, with stratification derangement) ; constantly lowered pressure of both sphincters (assessed by using a water manometer connected to the drainage port of a Foley catheter implanted into the stomach either through esophageal or duodenal incision) ; and both lower esophageal and pyloric sphincter failure. Throughout the esophagitis experiment, BPC 157 was given at either 10 μg/kg, i.p., once a day (last application 24 h before assessment) or alternatively, it was given continuously in drinking water at 0.16 μg/ml (12 ml /rat). This treatment recovers i) esophagitis (macroscopically and microscopically, at either region or investigated time period) and ii) pressure in both sphincters (cmH2O). In addition, BPC 157 (10 μg/ kg) or saline (1 ml/ rat, 5 ml /kg) was specifically given directly into the stomach ; pressure assessment was performed at 5 min thereafter. The effect of BPC 157 is specific because in normal rats, it increases lower esophageal sphincter-pressure, but decreases pyloric sphincter-pressure. Ranitidine, given as the standard drug using the same protocol (50 mg/kg, i.p., once daily ; 0.83 mg/ ml in drinking water ; or 50 mg/ kg directly into the stomach) had no effect.
Izvorni jezik: eng
Rad je indeksiran u
bazama podataka:
Current Contents Connect (CCC)
MEDLINE
Scopus
SCI-EXP, SSCI i/ili A&HCI
Science Citation Index Expanded (SCI-EXP) (sastavni dio Web of Science Core Collectiona)
Kategorija: Znanstveni
URL Internet adrese: https://www.jstage.jst.go.jp/article/jphs/102/3/102_3_269/_article
http://doi.org/10.1254/jphs.FP0060070
Broj citata:
Altmetric:
DOI: 10.1254/jphs.FP0060070
URL cjelovitog teksta:
Google Scholar: An Experimental Model of Prolonged Esophagitis With Sphincter Failure in the Rat and the Therapeutic Potential of Gastric Pentadecapeptide BPC 157
Upisao u CROSBI: ipetrovi@kbc-zagreb.hr (ipetrovi@kbc-zagreb.hr), 22. Ruj. 2011. u 13:15 sati



  Verzija za printanje   za tiskati


upomoc
foot_4